Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system

BACKGROUND: Clinical guidelines have recommended adjuvant chemotherapy (ACT) for patients with high-risk stage II colon cancer, although the survival benefit is unclear. ACT is also recommended for patients with stage III colon cancer to reduce the risk of recurrence and mortality. For stage II/III...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yilin, Shankaran, Veena, Hahn, Erin E, Haupt, Eric C, Bansal, Aasthaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387960/
https://www.ncbi.nlm.nih.gov/pubmed/37276035
http://dx.doi.org/10.18553/jmcp.2023.29.6.635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387960/
https://www.ncbi.nlm.nih.gov/pubmed/37276035
http://dx.doi.org/10.18553/jmcp.2023.29.6.635

Ejemplares similares